|
Feb 18
|
Blade Air Mobility Leads The Charge Among 3 US Penny Stocks
|
|
Feb 14
|
All You Need to Know About PLIANT THERAPT (PLRX) Rating Upgrade to Buy
|
|
Feb 13
|
Pliant Therapeutics to Assemble Expert Panel to Review BEACON-IPF Trial Data; Shares Jump
|
|
Feb 13
|
Neumora shakes up its C-suite; Biogen cuts early-stage pipeline
|
|
Feb 13
|
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
|
|
Feb 11
|
Pliant Therapeutics downgraded to Neutral from Overweight at JPMorgan
|
|
Feb 10
|
Pliant Therapeutics Pauses Enrollment in BEACON-IPF Trial, Shares Take Steep Dive
|
|
Feb 10
|
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
|
|
Feb 10
|
Pliant shares collapse as company halts fibrosis drug study
|
|
Jan 2
|
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Oct 5
|
Paradigm Biocapital Advisors LP Acquires New Stake in Pliant Therapeutics Inc
|
|
Oct 1
|
Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
|
|
Sep 30
|
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
|
Sep 24
|
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
|
|
Jul 15
|
Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Continued Antifibrotic and Anti-Cholestatic Activity Displayed Across Multiple Measures
|
|
Jun 13
|
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
|
|
May 14
|
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
|
|
May 8
|
Pliant Therapeutics First Quarter 2024 Earnings: US$0.78 loss per share (vs US$0.67 loss in 1Q 2023)
|
|
May 7
|
Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™
|
|
May 6
|
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
|